Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue

Issues

30,00 € / $42.00 / £23.00

Get Access to Full Text

Establishment of reference distributions and decision values for thyroid antibodies against thyroid peroxidase (TPOAb), thyroglobulin (TgAb) and the thyrotropin receptor (TRAb)

Esther A. Jensen1 / Per Hyltoft Petersen2 / Ole Blaabjerg3 / Pia Skov Hansen4 / Thomas H. Brix5 / Laszlo Hegedüs6

1.

2.

3.

4.

5.

6.

Corresponding author: Esther A. Jensen, Department of Clinical Biochemistry, Odense University Hospital, 5000 Odense C, Denmark Phone: +45-65-412865, Fax: +45-65-411911,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 44, Issue 8, Pages 991–998, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2006.166, July 2006

Publication History

Received:
February 16, 2006
Accepted:
May 3, 2006
Published Online:
2006-07-31

Abstract

Background: The National Academy of Clinical Biochemistry (NACB) stresses that the reference intervals for thyroid peroxidase antibodies (TPOAb), thyroglobulin antibodies (TgAb) and thyroid stimulating hormone (TSH)-receptor antibodies (TRAb) should be based on young men who lack certain risk factors and have serum TSH between 0.5 and 2.0 mIU/L. However, some young men without any of the risk factors have autoantibodies, and cannot be identified by the present tools. A model for reference intervals and cut-off values should not be influenced by the prevalence of risk factors.

Methods: We developed a model of “composite logarithmic Gaussian distributions” and tested it in 1441 well-characterised subjects without clinically overt thyroid disease.

Results: TPOAb and TgAb could be measured in all individuals. The 97.5% upper limits 1) on a traditional non-parametric scale, 2) according to the NACB criteria, and 3) for our model were 284, 24 and 9.8 kIU/L for TPOAb, and 84, 22 and 19 kIU/L for TgAb, respectively. The decision value (defined as the concentration corresponding to 0.1% false positives) was 15 kIU/L for TPOAb and 31 kIU/L for TgAb. Concentrations above our reference intervals affected the corresponding distribution of TSH values. For TRAb the upper reference limits were 1) 0.75 and 2) 0.75 IU/L, while our model was not applicable to TRAb because only 2–3% of the results were above the functional assay sensitivity.

Conclusions: In contrast to the NACB guidelines, our model for TPOAb and TgAb is more robust, as it is independent of the characteristics of the reference population.

Clin Chem Lab Med 2006;44:991–8.

Keywords: composite distributions; ln-Gaussian distributions; models; NACB guidelines; rankit plot; reference interval; thyroid antibodies; thyroid hormones

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
atieh amouzegar, mahmood bakhtiyari, mohammad ali mansournia, Ali Etemadi, Ladan Mehran, Maryam Tohidi, and Fereidoun Azizi
Thyroid, 2015
[2]
K. H. Winther, S. J. Bonnema, F. Cold, B. Debrabant, M. Nybo, S. Cold, and L. Hegedus
European Journal of Endocrinology, 2015, Volume 172, Number 6, Page 657
[3]
Thomas H. Brix, Laszlo Hegedüs, Anthony P. Weetman, and Helen E. Kemp
Clinical Endocrinology, 2014, Volume 81, Number 3, Page 440
[4]
D. Springer, T. Zima, and Z. Limanova
European Journal of Endocrinology, 2009, Volume 160, Number 5, Page 791
[5]
Katharina Taubner, Georg Schubert, Ferdinand Pulzer, Roland Pfaeffle, Antje Körner, Andreas Dietz, Joachim Thiery, Wieland Kiess, and Jürgen Kratzsch
Clinical Biochemistry, 2014, Volume 47, Number 1-2, Page 3
[6]
Morten Frost, Inge Petersen, Laszlo Hegedüs, Lene Christiansen, Thomas Brix, and Kaare Christensen
Thyroid, 2013, Volume 23, Number 7, Page 785
[7]
Morten Frost, Inge Petersen, Laszlo Hegedus, Lene Christiansen, Thomas Heiberg Brix, and Kaare Christensen
Thyroid, 2012, Page 120814054902005
[8]
L. Bazzichi, A. Rossi, C. Zirafa, F. Monzani, S. Tognini, A. Dardano, F. Santini, M. Tonacchera, M. De Servi, C. Giacomelli, F. De Feo, M. Doveri, G. Massimetti, and S. Bombardieri
Rheumatology International, 2012, Volume 32, Number 2, Page 335
[9]
D. Robert Dufour
Endocrinology and Metabolism Clinics of North America, 2007, Volume 36, Number 3, Page 579
[10]
Gudmundur H. Jorgensen, Arni E. Ornolfsson, Ari Johannesson, Sveinn Gudmundsson, Magdalena Janzi, Ning Wang, Lennart Hammarström, and Bjorn R. Ludviksson
Human Immunology, 2011, Volume 72, Number 2, Page 166
[11]
Nadia Abdelouahab, Donna Mergler, Larissa Takser, Claire Vanier, Melissa St-Jean, Mary Baldwin, Philip A. Spear, and Hing Man Chan
Environmental Research, 2008, Volume 107, Number 3, Page 380
[12]
Claus H. Nielsen, Thomas H. Brix, R. Graham Q. Leslie, and Laszlo Hegedüs
Clinical Immunology, 2009, Volume 133, Number 2, Page 218
[13]
Martin Gellerstedt and Per Hyltoft Petersen
Clinical Chemical Laboratory Medicine, 2007, Volume 45, Number 8
[14]
Nobuyuki Takasu and Jaeduk Yoshimura Noh
Expert Review of Clinical Immunology, 2008, Volume 4, Number 2, Page 221
[15]
Thomas H. Brix, Pia S. Hansen, Kirsten O. Kyvik, and Laszlo Hegedüs
Clinical Endocrinology, 2010, Volume 73, Number 5, Page 666
[16]
Claus H. Nielsen, Thomas H. Brix, Andrzej Gardas, J. Paul Banga, and Laszlo Hegedüs
Clinical Endocrinology, 2008, Volume 69, Number 4, Page 664
[17]
M. Bauer, T. Goetz, T. Glenn, and P. C. Whybrow
Journal of Neuroendocrinology, 2008, Volume 20, Number 10, Page 1101

Comments (0)

Please log in or register to comment.